New York State Cancer Registry Guide to Determine Reportability for Physician Medical Practices

First Page		Document Content
Date: 2011-04-06 14:08:05 International Classification of Diseases for Oncology Myeloproliferative disease ICD-10 Chapter II: Neoplasms Benign tumor Myelofibrosis Carcinoma Neuroendocrine tumor Myelodysplastic syndrome Carcinoid Medicine Oncology Anatomical pathology		New York State Cancer Registry Guide to Determine Reportability for Physician Medical Practices Add to Reading List Source URL: www.health.ny.gov Download Document from Source Website File Size: 29,63 KB Share Document on Facebook

	HAEMATOLOGY AUDIT TEMPLATE DocID: 1pL02 - View Document
	Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016 DocID: 1pn6V - View Document
	1 Dr Jürgen Thiele Institute for Pathology University of Cologne Kerpener Str. 62 DocID: 1ohLr - View Document
	Phase 2 trial of PRM-151, an anti-fibrotic agent, in patients with myelofibrosis: Stage 1 results Srdan Verstovsek1, Ruben Mesa2, Lynda Foltz3, Vikas Gupta4, John Mascarenhas5, Ellen Ritchie6, Ronald Hoffman5, Richard DocID: 19YPO - View Document
	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca DocID: 19fx5 - View Document